Literature DB >> 17488103

Synthesis and pharmacological evaluation of 6,7-indolo/thiazolo-morphinans--further SAR of levorphanol.

Ao Zhang1, Fuying Li, Chunyong Ding, Qizhen Yao, Brian I Knapp, Jean M Bidlack, John L Neumeyer.   

Abstract

To further extend the structure-activity relationships of levorphanol, two series of novel morphinans were prepared by incorporation of an indole or aminothiazole fragment to the hexyl ring (ring C) in levorphanol. Such morphinans differed from previously reported ligands in that such indole- or aminothiazole-containing morphinans displayed enhanced binding affinity to the delta opioid receptor, while the affinity to kappa and micro receptors was slightly reduced.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17488103     DOI: 10.1021/jm0701674

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

1.  Synthesis and pharmacological evaluation of hydrophobic esters and ethers of butorphanol at opioid receptors.

Authors:  Brian S Fulton; Brian I Knapp; Jean M Bidlack; John L Neumeyer
Journal:  Bioorg Med Chem Lett       Date:  2008-07-17       Impact factor: 2.823

2.  Rapid access to morphinones: removal of 4, 5-ether bridge with Pd-catalyzed triflate reduction.

Authors:  Christopher D Hupp; John L Neumeyer
Journal:  Tetrahedron Lett       Date:  2010-04-28       Impact factor: 2.415

3.  Synthesis and pharmacological evaluation of aminothiazolomorphinans at the mu and kappa opioid receptors.

Authors:  Brian A Provencher; Anna W Sromek; Wei Li; Shayla Russell; Elena Chartoff; Brian I Knapp; Jean M Bidlack; John L Neumeyer
Journal:  J Med Chem       Date:  2013-10-29       Impact factor: 7.446

4.  3-Hydroxy-4-methoxyindolomorphinans as delta opioid selective ligands.

Authors:  Trudy A Smith; Linn N Thatcher; Andrew Coop
Journal:  Bioorg Med Chem Lett       Date:  2007-07-04       Impact factor: 2.823

5.  Verifying the role of 3-hydroxy of 17-cyclopropylmethyl-4,5α-epoxy-3,14β-dihydroxy-6β-[(4'-pyridyl) carboxamido]morphinan derivatives via their binding affinity and selectivity profiles on opioid receptors.

Authors:  Boshi Huang; Rama Gunta; Huiqun Wang; Mengchu Li; Danni Cao; Rolando E Mendez; James C Gillespie; Chongguang Chen; Lan-Hsuan M Huang; Lee-Yuan Liu-Chen; Dana E Selley; Yan Zhang
Journal:  Bioorg Chem       Date:  2021-02-09       Impact factor: 5.275

6.  Controlling opioid receptor functional selectivity by targeting distinct subpockets of the orthosteric site.

Authors:  Rajendra Uprety; Tao Che; Saheem A Zaidi; Steven G Grinnell; Balázs R Varga; Abdelfattah Faouzi; Samuel T Slocum; Abdullah Allaoa; András Varadi; Melissa Nelson; Sarah M Bernhard; Elizaveta Kulko; Valerie Le Rouzic; Shainnel O Eans; Chloe A Simons; Amanda Hunkele; Joan Subrath; Ying Xian Pan; Jonathan A Javitch; Jay P McLaughlin; Bryan L Roth; Gavril W Pasternak; Vsevolod Katritch; Susruta Majumdar
Journal:  Elife       Date:  2021-02-08       Impact factor: 8.140

7.  Economical synthesis of 13C-labeled opiates, cocaine derivatives and selected urinary metabolites by derivatization of the natural products.

Authors:  Morten Karlsen; Huiling Liu; Jon Eigill Johansen; Bård Helge Hoff
Journal:  Molecules       Date:  2015-03-25       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.